Ontvang nu dagelijks onze kooptips!

word abonnee
IEX 25 jaar
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
Markt vandaag Koersen Forum Premium IEX Expert
Home  /   Forum   /   Celyad   /   celyad 2020

Aandeel Celyad BRU:CYAD.BL, BE0974260896

Laatste koers (eur) Verschil Volume
0,701   -0,029   (-3,97%) Dagrange 0,700 - 0,734 21.715   Gem. (3M) 89,2K

celyad 2020

Volgen
3.398 Posts
Pagina: «« 1 ... 68 69 70 71 72 ... 170 »» | Laatste | Omlaag ↓
  1. Speedbul 23 februari 2020 12:45
    @Twin. For the DEPLETHINK trial, 2 new centres in Belgium have been added (Antwerp and Brugge) and 1 US center has changed status from "not yet recruiting" to "recruiting".
    So in total we have 8 centres out of which 4 are "recruiting" in the US and 4 sites in Belgium (2 are "recruiting" and the 2 new ones are "not yet recruiting").
    The total anticipated number of patients is 52 out of which 9 patients (6 with dose 1 and 3 with dose 2) USING THE mAb MANUFACTURING PROCESS were enrolled at the time of the meeting "meet the management" from 8/1/2020. The comments from Frédéric Lehmann during the presentation = "the results are not very encouraging" with the mAb manufacturing process..
    Since then (July 2019), Celyad received the green light to use the OPTIMAB MANUFACTURING PROCESS which will be used for all new patients: 3 other patients at dose 2 and all patients at dose 3.
    Now that Celyad is extending the number of trial centers to 8 may suggest that the OptimAb process is boosting the performance.
    One billion cells per infusion cohort to begin in Q1 2020 - autologous + preconditionning + OptimAb process with CYAD-01
  10. forum rang 4 Wittman 24 februari 2020 10:09
    quote:

    uw4ever schreef op 24 februari 2020 09:50:

    The comments from Frédéric Lehmann during the presentation = "the results are not very encouraging
    Lijkt me toch niet positief?
    Graag de daaropvolgende zin ook meenemen in de context: "Since then (July 2019), Celyad received the green light to use the OPTIMAB MANUFACTURING PROCESS which will be used for all new patients: 3 other patients at dose 2 and all patients at dose 3. Now that Celyad is extending the number of trial centers to 8 may suggest that the OptimAb process is boosting the performance."
  11. Speedbul 24 februari 2020 10:32
    The results of Deplethink with the mAb manufacturing Process were not very encouraging COMPARING to the THINK STUDY(without preconditionning); meaning that it seem's that the preconditionning was not adding much value.
    Now with the use of the OptimAb Manufacturing process, it may be another story...
  14. forum rang 4 Wittman 24 februari 2020 11:43
    quote:

    Speedbul schreef op 24 februari 2020 10:37:

    Remember that ARMISTICE has still 300.000 shares as shortsell.
    By looking at this morning's volume, Armistice may be active today
    Agreed – although I don't see one reason why they (Armistice) should have any more insights or knowledge than all other investors combined.
3.398 Posts
Pagina: «« 1 ... 68 69 70 71 72 ... 170 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Premium drie voorbeelden van IEX Premium: de exclusieve content op de site, de app op een smartphone en IEX Magazine.

Benieuwd naar onze analyses en kooptips?

Word nu abonnee van IEX en krijg onbeperkt toegang tot onze (koop)tips en succesvolle modelportefeuilles. Nu 3 maanden voor slechts €19,95! Profiteer van 58% korting!

Word abonnee